Severity
Moderate
FDA Drug recall · Reported November 29, 2017
Presence of Foreign Tablets/Capsules.
Amerisource Health Services recalled Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American … - a moderate-severity action.
Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American … was recalled by Amerisource Health Services in November 29, 2017. Reason: Presence of Foreign Tablets/Capsules.. Check the official notice for the remedy. Verify recall #D-0091-2018 with the FDA Drug before acting.
The recall
Amerisource Health Services issued this moderate-severity FDA Drug recall-Presence of Foreign Tablets/Capsules..
Sourced from official FDA Drug enforcement records. Verify recall #D-0091-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0091-2018) was formally reported on November 29, 2017, with the manufacturer initiating the action on October 24, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. Amerisource Health Services is listed as the recalling firm, operating out of Columbus, OH. Federal records list the affected scope as 74 cartons (cartons of 100 individual unit doses).
The documented reason for this recall is: Presence of Foreign Tablets/Capsules. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
74 cartons (cartons of 100 individual unit doses)
Related Recalls
6
5 from same agency
Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Columbus, Ohio 43217, NDC 68084-046-01
Presence of Foreign Tablets/Capsules.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0091-2018 |
| Date reported | November 29, 2017 |
| Date initiated | October 24, 2017 |
| Recalling firm | Amerisource Health Services |
| Firm location | Columbus, OH |
| Affected scope | 74 cartons (cartons of 100 individual unit doses) |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported November 29, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.